FDA Inspection 1300144 - Novartis Pharmaceuticals Corporation - February 06, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novartis Pharmaceuticals Corporation

Record Details

This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on February 6, 2026, issued by the New Jersey District Office, covering biologics.

Company: Novartis Pharmaceuticals Corporation
Inspection Date: February 6, 2026
Product Type: Biologics
Office: New Jersey District Office

Open in Dashboard

ID · dda9986d-7403-4915-9abe-66007c22736d

Violation Codes3

21 CFR 211.113(b)21 CFR 211.19221 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.